Li A.P. (Ed.) Drug-Drug Interactions: Scientific and Regulatory Perspectives

Academic Press, 1997. — 307 p.Drug–Drug Interactions is a comprehensive review of the scientific and regulatory perspectives of drug–drug interactions from the point-of-view of academia, industry, and government regulatory agencies. This book is intended for professionals in the pharmaceutical industry, health care, and governmental regulatory agencies. Topics of interest include the mechanistic understanding of drug–drug interactions, the prediction of drug–drug interaction potential of new drugs, and the avoidance of clinically significant drug–drug interaction in patients.Key Features.Provides useful references on the science of drug-drug interactions.
Describes in a basic and comprehensive manner drug-drug interactions from the mechanistic viewpoint.
Contains original data from academic and industrial laboratories.
Presents an overview of regulatory agency positions.Overview: Scientific Basis of Pharmacokinetic Drug-Drug Interactions.
Role of Cytochrome P₄₅₀ Enzymes in Drug-Drug Interactions.
The Liver as a Target for Chemical-Chemical Interactions.
Applications of Human Liver Microsomes in Metabolism-Based Drug-Drug Interactions.
Applications of Human Hepatocytes as an Experimental System for the Evaluation of Pharmacokinetic Drug-Drug Interactions.
Liver Slices as a Model in Drug Metabolism and Drug-Drug Interactions.
The Use of cDNA Expressed Human Cytochrome P450 Enzymes to Study Potential Drug-Drug Interactions.
Pharmacokinetics of Drug Interactions.
Experimental Models for Evaluating Enzyme Induction Potential of New Drug Candidates in Animals and Man and a Strategy for Their Use.
Metabolic Drug-Drug Interactions: Perspective from U.S. FDA Medical and Clinical Pharmacology Reviewers.
Drug Interactions: Perspectives of the Canadian Directorate.